42 pre-built oncology regimen profiles, covering common combination therapies including FOLFOX, FOLFIRI, carboplatin and paclitaxel, R-CHOP, ABVD, FOLFIRINOX, carboplatin and pemetrexed, checkpoint inhibitor combinations (pembrolizumab plus chemotherapy, nivolumab plus ipilimumab), antibody-drug conjugates, and CAR-T plus bridging regimens. Multi-drug attribution works out of the box without custom configuration.
Interactive demo
Try Burna right now, no sign up required.